Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic
Public ClinicalTrials.gov record NCT00696072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to find out what effect the combination of letrozole (brand name: Femara) and dasatinib (brand name: Sprycel) has on metastatic breast cancer compared to letrozole alone
Study identification
- NCT ID
- NCT00696072
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2008 (Type not available)
- Primary completion
- Jun 2014 (Actual)
- Completion
- Jun 2014 (Actual)
- Last update posted
- Jun 13, 2016
2008 – 2014
United States locations
- U.S. sites
- 27
- U.S. states
- 11
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northern Arizona Hematology & Oncology Associates | Sedona | Arizona | 86336 | — |
| Arizona Oncology Associates D.B.A. Hematology Oncology | Tucson | Arizona | 85704 | — |
| Rocky Mountain Cancer Centers | Denver | Colorado | 80220 | — |
| Florida Cancer Institute - New Hope | Hudson | Florida | 34667 | — |
| Central Indiana Cancer Centers | Carmel | Indiana | 46032 | — |
| New York Oncology Hematology, Pc | Troy | New York | 12180 | — |
| Dayton Oncology And Hematology | Kettering | Ohio | 45409 | — |
| Willamette Valley Cancer Center | Eugene | Oregon | 97401 | — |
| Northwest Cancer Specialists, Pc | Portland | Oregon | 97213 | — |
| Medical Oncology Associates | Kingston | Pennsylvania | 18704 | — |
| Texas Oncology-Central Austin Cancer Center | Austin | Texas | 78731 | — |
| Texas Oncology | Bedord | Texas | 76022 | — |
| Texas Cancer Center At Medical City | Dallas | Texas | 75230 | — |
| Texas Oncology | Dallas | Texas | 75231 | — |
| Texas Oncology Sammons Cancer Center | Dallas | Texas | 75246 | — |
| El Paso Cancer Treatment Ctr - East | El Paso | Texas | 79915 | — |
| Texas Oncology | Fort Worth | Texas | 76104 | — |
| Texas Oncology | Garland | Texas | 75042 | — |
| Texas Oncology | Houston | Texas | 77024 | — |
| Texas Oncology-Plano East | Plano | Texas | 75075 | — |
| Cancer Care Centers Of South Texas | San Antonio | Texas | 78217 | — |
| Texas Oncology Cancer Center - Sugar Land | Sugar Land | Texas | 77479 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Texas Oncology Cancer Care And Research Center | Waco | Texas | 76712 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| Oncology & Hematology Associates Of Southwest Virginia, Inc. | Salem | Virginia | 24153 | — |
| Yakima Valley Memorial Hospital/North Star Lodge | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00696072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 13, 2016 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00696072 live on ClinicalTrials.gov.